Glenmede Trust CO Na Regenxbio Inc. Transaction History

Glenmede Trust CO Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$26.52 - $49.35 $11,562 - $21,516	-436 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$27.01 - $40.26 $6,752 - $10,065	-250 Reduced 36.44%	436 $11,000
Q2 2020 Aug 14, 2020	BUY	$27.75 - $43.44 $3,912 - $6,125	141 Added 25.87%	686 $24,000
Q4 2019 Feb 12, 2020	BUY	$34.54 - $44.87 $11,467 - $14,896	332 Added 155.87%	545 $21,000
Q3 2019 Nov 14, 2019	SELL	$31.84 - $50.88 $636 - $1,017	-20 Reduced 8.58%	213 $7,000
Q4 2018 Feb 14, 2019	BUY	$39.11 - $75.15 $9,112 - $17,509	233 New	233 $9,000

191

43.5M

58.9K

58.4K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $467M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.